Rituximab Maintenance Ups Survival in MCL After Transplant Rituximab Maintenance Ups Survival in MCL After Transplant

Younger patients with mantle cell lymphoma who have undergone transplant should be given rituximab maintenance, the LyMa trial concludes.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news